Oppilan Pharma Ltd
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis (NCT05156125) | Oppilan Pharma Ltd | 2021-11-30 |
| A PK Dose Proportionality Study of OPL-002 in Healthy Volunteers (NCT04451811) | Oppilan Pharma Ltd | 2020-09-07 |
Track Oppilan Pharma Ltd automatically
Every clearance here is in the API, with alerts when new ones post.